Search for Clinical Trial Results
Phenylketonurias - 25 Studies Found
Status | Study |
Suspended |
Study Name: Liver Cell Transplant for Phenylketonuria Condition: Phenylketonuria Date: 2011-10-20 Interventions:
|
Suspended |
Study Name: Response to Phenylketonuria to Tetrahydrobiopterin (BH4) Condition: Phenylketonuria Date: 2005-10-25 Interventions: Drug: tetrahydrobiopterin (BH4) Either placebo or BH4, 10mg/kg/day will be given for three months. Then |
Completed |
Study Name: Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria Condition: Phenylketonuria Date: 2012-11-19 Interventions: Drug: Kuvan® Kuvan® (sapropterin dihydrochloride) will be administered orally at a dose of 20 |
Active, not recruiting |
Study Name: Kuvan®'s Effect on the Cognition of Children With Phenylketonuria Condition: Phenylketonuria Date: 2013-10-16 Interventions: Drug: Kuvan® Kuvan® oral soluble tablet will be administered once daily along with Phenylalani |
Completed |
Study Name: Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria Condition: Phenylketonuria Date: 2009-04-22 Interventions:
|
Completed |
Study Name: Sapropterin in Individuals With Phenylketonuria Condition: Phenylketonuria Date: 2008-08-01 Interventions: Drug: Sapropterin (Kuvan) 20mg/kg/day taken once daily or as otherwise prescribed by physician as standa |
Terminated |
Study Name: Phenylketonuria, Oxidative Stress, and BH4 Condition: Phenylketonuria Date: 2011-06-23 Interventions:
|
Terminated |
Study Name: Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria Condition: Phenylketonuria Date: 2013-10-31 Interventions:
|
Completed |
Study Name: The Brain, Neurological Features and Neuropsychological Functioning in Adults With Phenylketonuria: A Pilot Study Condition: Phenylketonuria Date: 2013-08-05 Interventions: Other: MRI |
Completed |
Study Name: Protein Requirements in Children With Phenylketonuria (PKU) Condition: Phenylketonuria Date: 2013-10-16 Interventions: Dietary Supplement: Protein intake Oral consumption of eig |